Piramal Enterprises announced that its board has approved a proposal to raise Rs 450 crore by issuing non-convertible debentures (NCDs) through a private placement.

The company's board of directors to consider and approve the issuance of NCDs up to Rs 75 crore along with the green shoe option to retain oversubscription up to Rs 375 crore.

Results | The non-bank lender reported a 16% YoY growth in total assets under management (AUM) at ₹78,362 crore. Shares of Piramal Enterprises Ltd ended at ₹915.50, down by ₹75.90, or 7.66%, on the ...

Net interest income grew by 13 per cent year-on-year (Y-o-Y) to Rs 940 crore in Q3 FY25 from Rs 835 crore in Q3 FY24. Net ...

Jefferies analyst Bhaskar Basu revised the price target for Piramal Enterprises Group (PIEL:IN) shares to INR811 from the previous INR820, while maintaining an Underperform rating on the stock. The ...

Piramal Enterprises Ltd (PEL) on Monday said it has reported a net profit of Rs 39 crore in the third quarter ended December ...

Piramal Enterprises Limited (PEL), erstwhile Piramal Healthcare Limited, is the flagship company of the Piramal Group, led by Ajay Piramal. Established in the 1980s, the Group is one of Indias ...

Nandini's accomplishments often draw attention to her family ties, particularly her brother Anand's marriage to Isha Ambani, ...

Stock Market Today: Piramal Enterprises share price gained more than 8% during the the intraday trades on Tuesday. Piramal Enterprises announced that it will be receiving post $140 million deal ...

Deviating from the conventional short ad films, its Parakh ads aim to redefine lending with authentic borrower narratives, ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...